Treatments for PTSD

Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD

Retrieved on: 
Monday, July 12, 2021
Psychoactive drugs, Drugs, Entheogens, Euphoriants, MDMA, Methamphetamines, Stimulants, Post-traumatic stress disorder, Food and Drug Administration, Therapy, Multidisciplinary Association for Psychedelic Studies, Treatments for PTSD

This studyhas advanced through the pre-implementation stage at Numinus' Vancouver clinic and has now received the required federal regulatory approval.

Key Points: 
  • This studyhas advanced through the pre-implementation stage at Numinus' Vancouver clinic and has now received the required federal regulatory approval.
  • During the study, research, medical and therapist staff at Numinus will collectdata on the safety and effectiveness of MDMA-assisted therapyto informHealth Canada andsupport making MDMA-assisted therapy available toindividuals living with PTSD in Canada.
  • "Health Canada should be recognized for its ongoing leadership through its support of this study," said Dr. Christie.
  • These statements are no guarantee of future Health Canada or FDA approval or availability of MDMA-assisted therapy.

PPD Awarded US Army Study to Help Develop Post-Traumatic Stress Disorder Drugs

Retrieved on: 
Thursday, February 18, 2021
Mental health, Research, Other Defense, Clinical trials, Biotechnology, Health, Pharmaceutical, Science, Defense, Post-traumatic stress disorder, Articles, Psychiatry, Adverse childhood experiences, Medical specialties, Anxiety disorders, Aftermath of war, Mental health, Psychological trauma, PPD, Inc., Treatments for PTSD

PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, has been awarded Defense Health Agency funds to support a five-year Research Project Award (RPA) to develop and execute an adaptive platform clinical research trial of drug interventions to treat post-traumatic stress disorder (PTSD).

Key Points: 
  • PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, has been awarded Defense Health Agency funds to support a five-year Research Project Award (RPA) to develop and execute an adaptive platform clinical research trial of drug interventions to treat post-traumatic stress disorder (PTSD).
  • The RPA is part of the Medical Technology Enterprise Consortium (MTEC) that is under an Other Transaction Authority with the USAMRDC.
  • As an MTEC member, PPD supports ongoing efforts to expand and grow additional important public health research programs like PTSD for the Department of Defense and U.S. Army.
  • Some people develop the disorder after experiencing or witnessing a life-threatening event, such as military combat, a natural disaster, a car accident or a sexual assault.

CBC Offers Trauma and PTSD Training Series for Therapists, Psychologists, and other Mental Health Professionals

Retrieved on: 
Monday, September 14, 2020
Articles, Psychiatry, Mind, Adverse childhood experiences, Cognitive behavioral therapy, Post-traumatic stress disorder, Psychotherapy, Anxiety disorders, Cognitive processing therapy, Psychological trauma, Complex post-traumatic stress disorder, Treatments for PTSD

In response, Cognitive and Behavioral Consultants (CBC) will be launching a Trauma Training Series http://bit.ly/cbctrauma in collaboration with Dr. Elissa Brown of St. John's University.

Key Points: 
  • In response, Cognitive and Behavioral Consultants (CBC) will be launching a Trauma Training Series http://bit.ly/cbctrauma in collaboration with Dr. Elissa Brown of St. John's University.
  • The first workshop on cognitive behavioral therapy for adults with PTSD is designed for mental health professionals interested in pursuing specialized training to deepen their understanding of CBT approaches for treating trauma and PTSD symptoms, primarily Prolonged Exposure (PE).
  • Find additional information or to register please visit the Trauma Training Event Page on our website by http://bit.ly/cbctrauma .
  • She has extensive training and experience treating trauma and PTSD utilizing Prolonged Exposure, Cognitive Processing Therapy, and DBT-PE.

electroCore Announces Publication in Brain Stimulation Highlighting Non-Invasive Vagal Nerve Stimulation’s (nVNS) Potential Role in Treatment of Post-Traumatic Stress Disorder (PTSD)

Retrieved on: 
Thursday, August 27, 2020
Articles, Clinical medicine, Medicine, Post-traumatic stress disorder, RTT, Adverse childhood experiences, Headaches, Stress, Treatments for PTSD, Migraine, Cluster headache, Antidepressant

The data further suggests the activity of nVNS was seen immediately upon exposure to the traumatic stimuli and provided a benefit throughout the duration of emotional stress.

Key Points: 
  • The data further suggests the activity of nVNS was seen immediately upon exposure to the traumatic stimuli and provided a benefit throughout the duration of emotional stress.
  • The authors suggest that the results of this study provide evidence that nVNS may have utility as a treatment for many psychiatric disorders such as PTSD.
  • In fact, a report from the Institute of Medicine concluded that there is insufficient evidence for standard antidepressant treatments for PTSD.
  • The companys current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

Government of Canada Consults on Post-Traumatic Stress Disorder

Retrieved on: 
Wednesday, April 10, 2019
Articles, Psychiatry, Human behavior, Posttraumatic stress disorder, Mental health, Anxiety disorders, Military medicine, Military sociology, Psychological trauma, After the Sirens, Treatments for PTSD

OTTAWA, April 10, 2019 /CNW/ -Post-traumatic stress disorder (PTSD) has a profound impact on individuals, workplaces, communities and families affected by it.

Key Points: 
  • OTTAWA, April 10, 2019 /CNW/ -Post-traumatic stress disorder (PTSD) has a profound impact on individuals, workplaces, communities and families affected by it.
  • The National Conference on PTSD fulfills a key component of the Federal Framework on PostTraumatic Stress Disorder Act.
  • "PTSD is an important health issue, and one that the Government of Canada is committed to addressing.
  • On April 8, 2019, the Government of Canada released an Action Plan on Post-Traumatic Stress Injuries.